Recent News

• 04.22.2025 - Lifecore Biomedical to Participate at Upcoming CDMO Live 2025 Conference
• 04.16.2025 - Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 04.14.2025 - Lifecore Biomedical Appoints Thomas D. Salus as Chief Legal and Administration Officer
• 04.03.2025 - Q3 2025 Lifecore Biomedical Earnings Conference Call
• 04.03.2025 - Lifecore Biomedical Reports Third Quarter Fiscal 2025 Financial Results and Provides Corporate Update
• 03.27.2025 - Lifecore Biomedical to Report Financial Results for Third Quarter of Fiscal 2025 on April 3, 2025
• 03.17.2025 - Humanetics Selects Lifecore Biomedical to Deliver CDMO Services Supporting Development of BIO 300 for the Prevention of Acute Radiation Syndrome
• 03.04.2025 - TD Cowen 45th Annual Health Care Conference
• 02.26.2025 - Lifecore Biomedical to Participate in Upcoming Investor and Industry Conferences

Recent Filings

• 04.16.2025 - 3 Initial statement of beneficial ownership of securities
• 04.16.2025 - 8-K Current report
• 04.16.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.10.2025 - 8-K Current report
• 04.03.2025 - EX-99.1 EX-99.1
• 04.03.2025 - 8-K Current report
• 04.03.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 02.27.2025 - DEF 14A Other definitive proxy statements
• 02.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors